137 related articles for article (PubMed ID: 12762384)
1. Risk factors for sterile hemorrhagic cystitis in dogs with lymphoma receiving cyclophosphamide with or without concurrent administration of furosemide: 216 cases (1990-1996).
Charney SC; Bergman PJ; Hohenhaus AE; McKnight JA
J Am Vet Med Assoc; 2003 May; 222(10):1388-93. PubMed ID: 12762384
[TBL] [Abstract][Full Text] [Related]
2. Incidence of sterile hemorrhagic cystitis in dogs receiving cyclophosphamide orally for three days without concurrent furosemide as part of a chemotherapeutic treatment for lymphoma: 57 cases (2007-2012).
Best MP; Fry DR
J Am Vet Med Assoc; 2013 Oct; 243(7):1025-9. PubMed ID: 24050570
[TBL] [Abstract][Full Text] [Related]
3. Incidence of sterile hemorrhagic cystitis in tumor-bearing dogs concurrently treated with oral metronomic cyclophosphamide chemotherapy and furosemide: 55 cases (2009-2015).
Chan CM; Frimberger AE; Moore AS
J Am Vet Med Assoc; 2016 Dec; 249(12):1408-1414. PubMed ID: 27901449
[TBL] [Abstract][Full Text] [Related]
4. Mesna and furosemide for prevention of cyclophosphamide-induced sterile haemorrhagic cystitis in dogs--a retrospective study.
Laberke S; Zenker I; Hirschberger J
Vet Rec; 2014 Mar; 174(10):250. PubMed ID: 24463993
[TBL] [Abstract][Full Text] [Related]
5. Furosemide for prevention of cyclophosphamide-associated sterile haemorrhagic cystitis in dogs receiving metronomic low-dose oral cyclophosphamide.
Setyo L; Ma M; Bunn T; Wyatt K; Wang P
Vet Comp Oncol; 2017 Dec; 15(4):1468-1478. PubMed ID: 28194917
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Sterile Hemorrhagic Cystitis in Dogs Treated with Cyclophosphamide and Low-Dose Furosemide.
Iwaki Y; Gagnon J; MacDonald-Dickinson V
J Am Anim Hosp Assoc; 2022 Mar; 58(2):85-90. PubMed ID: 35195711
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for development of sterile haemorrhagic cystitis in canine lymphoma patients receiving oral cyclophosphamide: a case-control study.
Gaeta R; Brown D; Cohen R; Sorenmo K
Vet Comp Oncol; 2014 Dec; 12(4):277-86. PubMed ID: 23078083
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Canine Multicentric Lymphoma after Single or Divided Treatment with Cyclophosphamide in Multidrug Chemotherapy.
Lee JJ; Liao AT; Wang SL
Top Companion Anim Med; 2020 Nov; 41():100461. PubMed ID: 32823160
[TBL] [Abstract][Full Text] [Related]
9. Acute sterile hemorrhagic cystitis after a single intravenous administration of cyclophosphamide in three dogs.
Peterson JL; Couto CG; Hammer AS; Ayl RD
J Am Vet Med Assoc; 1992 Nov; 201(10):1572-4. PubMed ID: 1289337
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cyclophosphamide-induced hemorrhagic cystitis in five dogs.
Laing EJ; Miller CW; Cochrane SM
J Am Vet Med Assoc; 1988 Jul; 193(2):233-6. PubMed ID: 3403354
[TBL] [Abstract][Full Text] [Related]
11. Intravesical instillation of dilute formalin for treatment of cyclophosphamide-induced hemorrhagic cystitis in two dogs.
Weller RE
J Am Vet Med Assoc; 1978 May; 172(10):1206-9. PubMed ID: 566262
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of lomustine in combination with cyclophosphamide in dogs with lymphoma.
Rassnick KM; Bailey DB; Malone EK; Flory AB; Kiselow MA; Intile JL
J Am Anim Hosp Assoc; 2014; 50(3):167-73. PubMed ID: 24659727
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of metronomic cyclophosphamide chemotherapy in a UK population of cancer-bearing dogs: a retrospective study.
Harper A; Blackwood L
J Small Anim Pract; 2017 Apr; 58(4):227-230. PubMed ID: 28133740
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cyclophosphamide-induced cystitis.
Henness AM
J Am Vet Med Assoc; 1985 Jul; 187(1):4-5. PubMed ID: 4019300
[No Abstract] [Full Text] [Related]
15. Incidence of hemorrhagic cystitis after cyclophosphamide therapy with or without mesna: A cohort study and comprehensive literature review.
Almalag HM; Alasmari SS; Alrayes MH; Binhameed MA; Alsudairi RA; Alosaimi MM; Alnasser GA; Abuzaid RA; Khalil N; Abouzaid HH; Alarfaj AS
J Oncol Pharm Pract; 2021 Mar; 27(2):340-349. PubMed ID: 32356687
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer.
Matsuyama A; Woods JP; Mutsaers AJ
Can Vet J; 2017 Jan; 58(1):51-55. PubMed ID: 28042155
[TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic cystitis in children treated with alkylating agent cyclophosphamide: The experience of a medical center in Taiwan.
Wang CC; Weng TI; Lu MY; Yang RS; Lin KH; Wu MH; Liu SH
J Formos Med Assoc; 2015 Aug; 114(8):691-7. PubMed ID: 23880225
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-S-transferase-theta genotypes and the risk of cyclophosphamide toxicity in dogs.
Ekena J; Wood E; Manchester A; Chun R; Trepanier LA
Vet Comp Oncol; 2018 Dec; 16(4):529-534. PubMed ID: 29984447
[TBL] [Abstract][Full Text] [Related]
19. Recovery from Cyclophosphamide Overdose in a Dog.
Finlay JR; Wyatt K; North C
J Am Anim Hosp Assoc; 2017; 53(4):230-235. PubMed ID: 28535135
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal toxicity after vincristine or cyclophosphamide administered with or without maropitant in dogs: a prospective randomised controlled study.
Mason SL; Grant IA; Elliott J; Cripps P; Blackwood L
J Small Anim Pract; 2014 Aug; 55(8):391-8. PubMed ID: 24920169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
